The analytical validation of an immunoenzymometric technique for the specific measurement of the creatine kinase-MB isoenzyme is described. Its application is shown in the diagnosis of myocardial infarction. A difference in the correlation of the mass and catalytic activity of the CK-MB isoenzyme is shown between patients suffering myocardial infarction and those with skeletal muscle damage.
References
1.
SomerHKonttinnenA. Demonstration of serum creatine kinase isoenzymes by a fluorescence technique. Clin Chim Acta1972; 40: 133–8.
2.
MercerDW. Separation of tissue and serum creatine kinase isoenzymes by ion exchange column chromatography. Clin Chem.1974; 20: 36–40.
3.
GerhardtWLjungdahlLBorjessonJCreatine kinase B-subunit activity in human serum. I. Development of an immunoinhibition method for routine determination of S-creatine kinase B-subunit activity. Clin Chim Acta1977; 78: 29–41.
4.
WicksRUsategui-GomezMMillerMWarshawM. Immunochemical determination of CK-MB isoenzyme in human serum. II. An enzymic approach. Clin Chem.1982; 28: 54–8.
Usategui-GomezMWicksRWFarrenkopfBImmunochemical determination of CK-MB isoenzyme in human serum: a radiometric approach. Clin Chem.1981; 27: 823–7.
7.
JacksonAPSiddleKThompsonRJ. Two site monoclonal antibody assays for human heart- and brain-type creatine kinase. Clin Chem.1984; 30: 1157–62.
8.
WurzburgUHennrichNLangH. Bestimmung der aktivitat von creatine-kinase MB in serum inter verwendung inhibierender antikorper. Klin Wochenschr1976; 54: 357–2.
9.
Scandinavian Committee on Enzymes of the Scandinavian Society for Clinical Chemistry and Clinical Physiology. Recommended method for the determination of creatine kinase in blood modified by the inclusion of EDTA. Scand J Clin Lab Invest1979; 39: 1–5.
10.
GerhardtWWaldenstromJ. Creatine kinase B-subunit activity in serum after immunoinhibition of M-subunit activity. Clin Chem.1979; 25: 1274–80.
11.
SteinW. Macro creatine kinases: methodological and clinical significance. In: BurnettRNGoetzWA, eds. CK-MB Methods and Clinical Significance. Darmstadt: GIT Verlag Ernst Giebeler, 1981; 61–74.
12.
WagnerGSRoeCRLimbirdLEThe importance of the identification of the myocardial-specific isoenzyme of creatine phosphokinase (MB form) in the diagnosis of acute myocardial infarction. Circulation1973; 47: 263–9.
PriceCPHallworthMJCobbanAJEvaluation of methods for the measurement of creatine kinase MB isoenzyme activity in serum. DHSS Evaluation Report1982, p. 99.
15.
WillsonVJCJonesHMThompsonRJ. A two site immunoradiometric assay for the MB isoenzyme of creatine kinase. Clin Chim Acta1981; 113: 153–63.
16.
FentonJJBrunstetterSGordonWCDiagnostic efficiency of a new enzyme immunoassay for creatine kinase MB isoenzyme. Clin Chem.1984; 30: 1399–401.
17.
ShahangianSAshKOWahlstromNOCreatine kinase and lactate dehydrogenase isoenzymes in serum of patients suffering burns, blunt trauma or myocardial infarction. Clin Chem.1984; 30: 1332–8.
18.
WeversRAOlthuisHPvan NielJCCA study on the dimeric structure of creatine kinase. Clin Chim Acta1977; 75: 377–85.
19.
GuslitsBGJacobsHK. Investigation of the heterogeneity of the MM isoenzyme of creatine kinase. Clin Chim Acta1983; 130: 55–69.
